The recent disruptions in global chains have highlighted the necessity of securing vital medications like Ivermectin. Relying on overseas producers exposes nations to significant vulnerabilities, including delivery delays, cost fluctuations, and even political risks. Transitioning towards domestic sourcing of Ivermectin offers a multitude of benefi